抗腫瘍性の

抗腫瘍薬は体内の腫瘍細胞に対して抑制と殺滅作用を備える薬物である。腫瘍の総合的な治療中で重要な位置を占め,特に外科手術によって治療できない白血病、播種性腫瘍の治療に非常に重要である。現在使用している抗腫瘍薬の多くは、DNA又はRNAの合成を抑制し、さらにDNA構造を破壊することによってその役割を果たす。各期間の腫瘍細胞への影響により,細胞周期特異性薬と細胞周期非特異性薬という二つの種類に分けられる。このような二つの種類の薬物は異なるが,骨髄の造血幹細胞及び他の成長周期が短い細胞に対していずれも一定の殺傷作用を備え,且つ生体防御反応を抑制することができる。抗腫瘍薬は種類が多く,以下の種類に分けられることができる:アルキル化剤類,例えばシクロホスファミド、グリシンホスホラミド、チオテパ等;代謝拮抗薬,例えばメトトレキセート、メルカプトプリン、5-フルオロウラシル、ヒドロキシウレア等;抗生物質類,例えばダクチノマイシン、マイトマイシンC、ブレオマイシン等;ホルモン等,例えばプレドニゾン、プロピオン酸テストステロン、ジエチルスチルベストロール等;あるボタニカルズ,例えばビンブラスチン、カンプトテシン、コルヒチン等;その他の種類,例えばプロカルバジン塩酸塩、レゾキサン、エチルジモルホリン等。抗腫瘍薬は非常に多いが、それらの作用機構が異なるため,臨床応用の場合に慎重に選択する必要がある。
Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
Surzebiclimab Surzebiclimab 2342597-90-2
SD-101 SD-101 1263078-66-5
フェラジリマブ(遺伝子組換え) フェラジリマブ(遺伝子組換え) 2252518-85-5
Oportuzumab Monatox Oportuzumab Monatox 945228-48-8
Lirilumab Lirilumab 1000676-41-4
Glycinamide, N2-[2-[2-[2-[[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]ethoxy]ethoxy]acetyl]-N-[(2S)-2-[4-(β-D-glucopyranuronosyloxy)-3-nitrophenyl]-2-[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]ethyl]-L-glutaminyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-meth Glycinamide, N2-[2-[2-[2-[[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]ethoxy]ethoxy]acetyl]-N-[(2S)-2-[4-(β-D-glucopyranuronosyloxy)-3-nitrophenyl]-2-[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]ethyl]-L-glutaminyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-meth 2983134-61-6 C87H112FN19O33
L-Asparagine, N-(1-β-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, hydrochloride (1:1) L-Asparagine, N-(1-β-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, hydrochloride (1:1) 2098942-57-3 C13H19ClN4O8
Milademetan Milademetan 1398568-47-2 C30H34Cl2FN5O4
Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT 2396667-62-0 C46H44N6O19
Zanidatamab Zanidatamab 2169946-15-8
アミバンタマブ(遺伝子組換え) アミバンタマブ(遺伝子組換え) 2171511-58-1
Vopratelimab Vopratelimab 2039148-04-2
Vecabrutinib succinate Vecabrutinib succinate 1947403-49-7 C26H30ClF4N7O6
キシノスタット塩酸塩 キシノスタット塩酸塩 1083078-98-1 C21H27ClN6O2
オンブラブリン塩酸塩 オンブラブリン塩酸塩 253426-24-3 C21H26N2O6.ClH
CLR-131 CLR-131 873438-88-1 C29H53INO4P
アンナマイシン アンナマイシン 92689-49-1 C26H25IO11
HM-30181 mesylate monohydrate HM-30181 mesylate monohydrate 2097125-58-9 C39H40N6O10S
AZD0364 AZD0364 2097416-76-5 C24H24F2N8O2
Imgatuzumab Imgatuzumab 959963-46-3
Pyrazolo[1,5-a]pyrimidine, 5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]-3-[4-(trifluoromethyl)-1H-pyrazol-1-yl]- Pyrazolo[1,5-a]pyrimidine, 5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]-3-[4-(trifluoromethyl)-1H-pyrazol-1-yl]- 2353522-15-1 C20H15F5N6
Research Grade Inbakicept  (DHE28302) Research Grade Inbakicept (DHE28302) 2135939-52-3
Mipasetamab Mipasetamab 2361055-48-1
MilatuzuMab MilatuzuMab 899796-83-9
Fexapotide triflutate Fexapotide triflutate 1609252-56-3 C92H164F3N27O27S
Ispinesib mesylate Ispinesib mesylate 514820-03-2 C31H37ClN4O5S
Linavonkibart Linavonkibart 2640981-30-0
KX2-391 (Mesylate) KX2-391 (Mesylate) 1080645-95-9 C27H33N3O6S
ベキスロステリド ベキスロステリド 148905-78-6 C14H16ClNO
Casdozokitug Casdozokitug 2643331-37-5
エプラツズマブ エプラツズマブ 205923-57-5
リフィラフェニブ リフィラフェニブ 1446090-79-4 C25H17F3N4O3
2-Buten-1-amine, 3-fluoro-4-(8-quinolinylsulfonyl)-, (2Z)- 2-Buten-1-amine, 3-fluoro-4-(8-quinolinylsulfonyl)-, (2Z)- 2409963-83-1 C13H13FN2O2S
L-Alaninamide, N-[10,10-dioxido-1,12-dioxo-14-[(1α,8α,9β)-bicyclo[6.1.0]non-4-yn-9-yl]-3,6,13-trioxa-10-thia-9,11-diazatetradec-1-yl]-L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]-11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]carbonyl]oxy]methyl]phenyl]- L-Alaninamide, N-[10,10-dioxido-1,12-dioxo-14-[(1α,8α,9β)-bicyclo[6.1.0]non-4-yn-9-yl]-3,6,13-trioxa-10-thia-9,11-diazatetradec-1-yl]-L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]-11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]carbonyl]oxy]methyl]phenyl]- 2126805-05-6 C66H83N9O18S
7H-8,12-Metheno-4H-pyrazolo[3,4-h]-1,2,3-triazolo[4,5-k][2,5]benzoxaazacyclotetradecin-11-amine, 7-ethyl-16-fluoro-2,14-dihydro-2,14-dimethyl-, (14R)- 7H-8,12-Metheno-4H-pyrazolo[3,4-h]-1,2,3-triazolo[4,5-k][2,5]benzoxaazacyclotetradecin-11-amine, 7-ethyl-16-fluoro-2,14-dihydro-2,14-dimethyl-, (14R)- 2739829-00-4 C22H22FN7O
サマリウム (153Sm)レキシドロナムナトリウム サマリウム (153Sm)レキシドロナムナトリウム 160369-78-8 C6H12N2Na5O12P4Sm
イタシチニブアジピン酸塩 イタシチニブアジピン酸塩 1334302-63-4 C32H33F4N9O5
4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- 1801344-14-8 C24H25N7O5
ラバクホサジン ラバクホサジン 859209-74-8 C21H35N8O6P
Falbikitug Falbikitug 2740565-02-8
チノスタムスチン チノスタムスチン 1236199-60-2 C19H28Cl2N4O2
1-Pyrrolidinecarboxamide, 3,3-dimethyl-N-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-oxo-, hydrochloride, hydrate (1:1:1) 1-Pyrrolidinecarboxamide, 3,3-dimethyl-N-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-oxo-, hydrochloride, hydrate (1:1:1) 2759304-23-7 C22H24N6O3.ClH.H2O
トレバナニブ(遺伝子組換え) トレバナニブ(遺伝子組換え) 894356-79-7
サラカチニブフマル酸塩 サラカチニブフマル酸塩 893428-72-3 C31H36ClN5O9
4F-ベンゾイル-TN14003 4F-ベンゾイル-TN14003 664334-36-5 C97H144FN33O19S2
レビマスタト レビマスタト 259188-38-0 C23H41N5O5S
Research Grade Davutamig Research Grade Davutamig 2648058-48-2
ピマセルチブ塩酸塩 ピマセルチブ塩酸塩 1236361-78-6 C15H16ClFIN3O3
アシビシン アシビシン 42228-92-2 C5H7ClN2O3
Fexapotide Fexapotide 492447-54-8 C90H163N27O25S
(S)-CFT7455 (S)-CFT7455 2504235-67-8 C28H27N3O4
Amatuximab Amatuximab 931402-35-6
1H-Isoindole-4-carboxamide, 2-(1-cyclohexyl-4-piperidinyl)-6-fluoro-2,3-dihydro-3-oxo- 1H-Isoindole-4-carboxamide, 2-(1-cyclohexyl-4-piperidinyl)-6-fluoro-2,3-dihydro-3-oxo- 1606995-47-4 C20H26FN3O2
メノガリル メノガリル 71628-96-1 C28H31NO10
Cobomarsensodium Cobomarsensodium 1848257-85-1
エディコチニブ エディコチニブ 1142363-52-7 C27H35N5O2
Pegdinetanib Pegdinetanib 906450-24-6 C27H46N6O13S
タノマスタット タノマスタット 179545-77-8 C23H19ClO3S
Berubicin hydrochloride Berubicin hydrochloride 293736-67-1 C34H35NO11. HCl
Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]- Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]- 2821770-49-2 C55H71N9O13S
エルサマイシンA エルサマイシンA 97068-30-9 C33H35NO13
Cofetuzumab Cofetuzumab 1869928-62-0
Research Grade Sozinibercept Research Grade Sozinibercept 2568358-31-4
Oncophage Oncophage 492448-75-6
Vonlerolizumab Vonlerolizumab 1638935-72-4
サリデギブ サリデギブ 1037210-93-7 C29H48N2O3S
Mirvetuximab Soravtansine Mirvetuximab Soravtansine 1453084-37-1
Ensituximab Ensituximab 1092658-06-4
エンザスタウリン塩酸塩 エンザスタウリン塩酸塩 359017-79-1 C32H29N5O2.ClH
エルブロゾール エルブロゾール 124784-31-2 C24H27N3O5S
Ozuriftamab Ozuriftamab 2460399-44-2
ネバニミブ ネバニミブ 133825-80-6 C27H39N3O
Farletuzumab ecteribulin Farletuzumab ecteribulin 2407465-18-1
Pelidotin Pelidotin 1438849-92-3 C68H100N12O14S
エソルビシン塩酸塩 エソルビシン塩酸塩 63950-06-1 C27H29NO10.ClH
ゾルバマイシン ゾルバマイシン 11056-20-5 C55H85N19O21S2
[2,5′-Bi-1H-imidazole]-5-carboxamide, 4′-(4-fluorophenyl)-1′-(1-methylethyl)-N-[4-(4-methyl-1-piperazinyl)phenyl]-, acetate (1:1) [2,5′-Bi-1H-imidazole]-5-carboxamide, 4′-(4-fluorophenyl)-1′-(1-methylethyl)-N-[4-(4-methyl-1-piperazinyl)phenyl]-, acetate (1:1) 2945838-77-5 C27H30FN7O.C2H4O2
Pacanalotamab Pacanalotamab 2251756-52-0
Depatuxizumab Depatuxizumab 1471999-69-5
Phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl- Phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl- 1372719-41-9 C30H16O8
パリホスファミド パリホスファミド 31645-39-3 C4H11Cl2N2O2P
L-Alanine, N-[(S)-[[(2S,4S)-4-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-dioxolan-2-yl]methoxy](4-bromophenoxy)phosphinyl]-, (1S)-1-methylbutyl ester L-Alanine, N-[(S)-[[(2S,4S)-4-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-dioxolan-2-yl]methoxy](4-bromophenoxy)phosphinyl]-, (1S)-1-methylbutyl ester 2129993-56-0 C22H30BrN4O8P
トシル酸インプロスルファン トシル酸インプロスルファン 32784-82-0
2-Piperazineacetonitrile, 4-[(7S)-7-[3-amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl]-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)- 2-Piperazineacetonitrile, 4-[(7S)-7-[3-amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl]-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)- 2914919-85-8 C32H35F6N7O3
6H-Imidazo[4,5-f]quinoline-6-carboxylic acid, 3-[(1R,3R)-3-carboxycyclohexyl]-2-[(R)-(5-fluoro-2-methoxyphenyl)hydroxymethyl]-3,7,8,9-tetrahydro-7-methyl-, 6-methyl ester, (7S)- 6H-Imidazo[4,5-f]quinoline-6-carboxylic acid, 3-[(1R,3R)-3-carboxycyclohexyl]-2-[(R)-(5-fluoro-2-methoxyphenyl)hydroxymethyl]-3,7,8,9-tetrahydro-7-methyl-, 6-methyl ester, (7S)- 2304372-79-8 C28H32FN3O6
Loncastuximab Tesirine Loncastuximab Tesirine 1879918-31-6
(2S)-2-[[(2S)-6,8-Difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]amino]-N-[1-[2-[(2,2-dimethylpropyl)amino]-1,1-dimethylethyl]-1H-imidazol-4-yl]pentanamide dihydrobromide (2S)-2-[[(2S)-6,8-Difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]amino]-N-[1-[2-[(2,2-dimethylpropyl)amino]-1,1-dimethylethyl]-1H-imidazol-4-yl]pentanamide dihydrobromide 1962925-29-6 C27H42BrF2N5O
ベロテカン塩酸塩 ベロテカン塩酸塩 213819-48-8 C25H28ClN3O4
Omburtamab Omburtamab 1895083-75-6
L-Alanine, N-[(S)-[[(2S,4S)-4-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-dioxolan-2-yl]methoxy](4-bromophenoxy)phosphinyl]-, (1S)-1-methylbutyl ester, hydrochloride (1:1) L-Alanine, N-[(S)-[[(2S,4S)-4-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-dioxolan-2-yl]methoxy](4-bromophenoxy)phosphinyl]-, (1S)-1-methylbutyl ester, hydrochloride (1:1) 2416950-25-7 C22H30BrN4O8P.ClH
ビンタフォリド ビンタフォリド 742092-03-1 C86H109N21O26S2
Trastuzumab Duocarmazine Trastuzumab Duocarmazine 1642152-40-6
Bomedemstat Bomedemstat 1990504-72-7 C35H42FN7O5S
Pegamotecan Pegamotecan 581079-18-7 C50H44N6O13(C2H4O)n
ティボザニブ塩酸塩水和物 ティボザニブ塩酸塩水和物 682745-41-1 C22H22Cl2N4O6
アムバチニブ塩酸塩 アムバチニブ塩酸塩 1055986-67-8 C23H22ClN5O3S
レバスチニブトシル酸塩 レバスチニブトシル酸塩 1033893-29-6 CH6ClNO
L-Lysine, 4N6,4′N6-[1,1′-[3,6,10,13,16,19-hexaazabicyclo[6.6.6]eicosane-1,8-diylbis[imino(1,5-dioxo-5,1-pentanediyl)]]bis(D-phenylalanyl-D-phenylalanyl-8-aminooctanoyl)]bis[N2-[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]- L-Lysine, 4N6,4′N6-[1,1′-[3,6,10,13,16,19-hexaazabicyclo[6.6.6]eicosane-1,8-diylbis[imino(1,5-dioxo-5,1-pentanediyl)]]bis(D-phenylalanyl-D-phenylalanyl-8-aminooctanoyl)]bis[N2-[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]- 2254661-83-9 C100H150N20O24
1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N′-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-, (2E)-2-butenedioate (2:1) 1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N′-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-, (2E)-2-butenedioate (2:1) 2444285-59-8 C29H25FN4O5.1/2C4H4O4
L-Tyrosine, N-acetylglycyl-L-valyl-L-arginyl-L-alanyl-L-lysyl-L-alanylglycyl-L-valyl-L-arginyl-L-asparaginyl-L-norleucyl-L-phenylalanyl-L-lysyl-L-seryl-L-α-glutamyl-L-seryl- L-Tyrosine, N-acetylglycyl-L-valyl-L-arginyl-L-alanyl-L-lysyl-L-alanylglycyl-L-valyl-L-arginyl-L-asparaginyl-L-norleucyl-L-phenylalanyl-L-lysyl-L-seryl-L-α-glutamyl-L-seryl- 2098662-44-1 C85H138N26O25
ホームページ | メンバー | 広告掲載 | お問い合わせ
Copyright © 2016 ChemicalBook All rights reserved.